Biosensing Instrument

08/27/2026

Biosensing Instrument will be at Discovery on Target 2026! Come see us at Booth #307 to say hi and learn more about our award winning technology.

Learn more about Discovery on Target 2026 here: https://www.discoveryontarget.com/

08/19/2026

Check out this paper from Yixian Wang at California State University, Los Angeles on accessing real-time interaction between antimicrobial liposomes and live Staphylococcus epidermidis using

Read it here: https://doi.org/10.1016/j.biosx.2026.100792

08/12/2026

Check out our newest Application Note on Agonist and Antagonist Peptide Binding Interaction Kinetics with GLP-1R!

Read it here: https://biosensingusa.com/application-notes/application-note-181-in-vitro-characterization-of-agonist-and-antagonist-peptide-binding-interaction-kinetics-to-glp-1r-in-hek293t-cells-using-spr-microscopy/

07/22/2026

Check out our latest AppNote on analysis of Malaria antigens!

Read more: https://biosensingusa.com/application-notes/application-note-180-surface-plasmon-resonance-analysis-of-chemically-synthesized-cyclic-malaria-antigen-pfama1-domain-i-binding-to-pfron2/

07/15/2026

Check out this paper on "Agonist and Antagonist Peptide Binding Interaction Kinetics" by our lovely team Miyuki Thirumurthy, Jesus Aguilar Diaz de leon, and Nguyen (Win) Ly, PhD as well as Shuchong Pan from Mayo Clinic

Read it here:

The glucagon peptide 1 receptor (GLP-1R), a class-B-type G protein-coupled receptor (GPCR), is a key therapeutic target for many metabolic disorders, including obesity and type 2 diabetes, due to its central role in glucose homeostasis and insulin secretion. Despite its pharmacological importance, s...

06/30/2026

Check out this paper by Kris Borzilleri, Jonathan Brooks, and Felix Vajdos "Discovery of Potent and Brain-Penetrant Inverse Agonists for GPR61, an Orphan G Protein-Coupled Receptor"!

Read it here:

GPR61 is a class A orphan G protein-coupled receptor (GPCR) that is predominantly expressed in the pituitary gland and appetite-regulating centers of the brain. Genome-wide association analysis, epigenetic analysis, and animal model data have suggested that GPR61 could be a potential therapeutic tar...

06/17/2026

Still wondering if our is a good fit for you? These are just a few of the applications our newest SPRm 220 can do!

Learn more on our website here: https://biosensingusa.com/products/instruments/bi-sprm220/

05/26/2026

Check out our latest Application Note on Live-Cell Binding Analysis Targeting GLP-1R!

Read it here: https://biosensingusa.com/application-notes/application-note-178-modality-dependent-binding-to-glp-1r-on-live-cells/

05/19/2026

Congratulations to the researchers at Jagiellonian University for their published paper with the first use of to assess dual-activity interactions with the histamine H3 receptor ligands and MAO-B inhibitors.

Read it here: https://www.mdpi.com/1422-0067/27/2/581

Chalcone-based derivatives were designed as dual-acting ligands targeting the histamine H3 receptor (H3R) and monoamine oxidase B (MAO-B), based on the lead compound DL76. Three series of compounds (1–18) were synthesised and characterised, including simple chalcones (1–9) and piperidinyl chalco...

05/13/2026

The Poster presented by our friends at Eurofins DiscoverX on "Integrated evaluation of payload-, Fc-, and target-mediated mechanisms of ADCs using streamlined complementary platforms" is now available for download!

Read it here: https://biosensingusa.com/application-notes/application-note-177-integrated-evaluation-of-payload-fc-and-target-mediated-mechanisms-of-adcs-using-streamlined-complementary-platforms/

Biosensing Instrument is a life science company that designs award winning label-free molecular interaction instruments using the SPR technology.